Kaya Holdings Inc. (KAYS)

[abracky]

Kaya Holdings Greek and Israeli Medical Cannabis Projects Zoom Update Today at 2:00 PM EST

September 2, 2020, 12:00 PM EDT·9 mins read

KAYS to report to shareholders on Q-2 results of operations, progress of medical cannabis cultivation projects in Greece and Israel, and other business developments
FORT LAUDERDALE, FL / ACCESSWIRE / September 2, 2020 / Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS), the first U.S. publicly traded company to vertically integrate cannabis retail, cultivation and processing operations confirmed that the online shareholder webinar will today Wednesday, September 2, 2020 at 2:00 PM Eastern Time.
Seating is limited so please register now using the following link to reserve your place for the program:


https://us02web.zoom.us/webinar/register/WN_fdKpjk8oTnWZeOzIwc2klw
After registering, you will receive a confirmation email containing information about joining the webinar. If you do not receive a confirmation email, please contact us via email at [e-mail] and we will assist you.
Participants will be able to view the presentation live on their computer, tablet or smartphone. The presentation is expected to last between 60-90 minutes and will feature online live discussion with Craig Frank, KAYS Chairman and CEO and W. David Jones, Senior Advisor for Business Development and Financial Operations, as well as live onsite reports from Management and Staff in Oregon, Greece and Israel.

Topics to be covered will include:

Results of Financial Operations for the three and six month periods ending June 30, 2020, as reported on KAYS recently filed Form 10-Q.

Reports on progress of our subsidiary Kaya Brands International, Inc.'s medical marijuana cultivation projects in Greece and Israel. These two facilities, as currently envisioned (and after obtaining successful financing, completing construction and obtaining final requisite licensing), are configured to produce approximately 600,000 pounds of GMP Certified, Premium Medical Grade, Cannabis annually for potential export to the European Union and elsewhere.

Other general business developments.

"We have spent the last two years planning on the expansion of our business by developing international opportunities for KAYS. Management had determined that international projects would enable KAYS to leverage its 6+ years in the U.S. cannabis industry to foster growth and build increase shareholder value," stated KAYS CEO Craig Frank. "We look forward on reporting KAYS' progress shareholders."
About Kaya Holdings, Inc. (www.kayaholdings.com)
Kaya Holdings, Inc. ("KAYS") is a touch-the-plant vertically integrated legal cannabis company operating a number of majority-owned subsidiaries that retail, cultivate, produce and distribute premium medical and recreational cannabis products, including flower, concentrates, oils and extracts, cannabis-infused foods and beverages, topicals and cannaceuticals. KAYS is a fully reporting, US-based publicly traded company, listed for trading on the OTCQB Tier of the over-the-counter market under the symbol OTCQB:KAYS.
Summary of Operations
KAYS corporate structure includes the following three majority-owned subsidiaries, each responding to various demands and opportunities in the cannabis industry:
Marijuana Holdings Americas, Inc. owns the Kaya Shack™ brand of licensed medical and recreational marijuana stores (www.kayashack.com) and the Kaya Farms™ brand of cannabis production and processing operations that operate in the United States. Kaya Brands USA, Inc. owns a wide range of proprietary brands of cannabis extracts, oils, pre-rolls, topicals, food and beverages, cannaceuticals and related accessories. Kaya Brands International, Inc., was founded to serve as the vehicle for the Company's non-U.S. operations including retail franchising in Canada and cultivation activities in Greece and Israel.